Allgens Medical Technology CO., LTD. (688613.SS)
CNY 15.9
(1.08%)
CNY 15.9
(1.08%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.52 Billion CNY | 4.59% |
| 2022 | 1.45 Billion CNY | 2.32% |
| 2021 | 1.42 Billion CNY | 77.17% |
| 2020 | 804.93 Million CNY | 12.41% |
| 2019 | 716.07 Million CNY | 36.37% |
| 2018 | 525.09 Million CNY | 63.85% |
| 2017 | 320.46 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.55 Billion CNY | -0.51% |
| 2024 Q2 | 1.56 Billion CNY | 2.76% |
| 2024 Q1 | 1.52 Billion CNY | -0.37% |
| 2023 Q4 | 1.52 Billion CNY | 1.65% |
| 2023 FY | 1.52 Billion CNY | 4.59% |
| 2023 Q3 | 1.5 Billion CNY | 0.18% |
| 2023 Q2 | 1.49 Billion CNY | 1.69% |
| 2023 Q1 | 1.47 Billion CNY | 1.01% |
| 2022 Q3 | 1.44 Billion CNY | -1.25% |
| 2022 Q2 | 1.46 Billion CNY | 2.09% |
| 2022 Q1 | 1.43 Billion CNY | 0.41% |
| 2022 FY | 1.45 Billion CNY | 2.32% |
| 2022 Q4 | 1.45 Billion CNY | 1.09% |
| 2021 Q1 | 841.58 Million CNY | 4.55% |
| 2021 FY | 1.42 Billion CNY | 77.17% |
| 2021 Q3 | 1.38 Billion CNY | 0.62% |
| 2021 Q4 | 1.42 Billion CNY | 2.84% |
| 2021 Q2 | 1.37 Billion CNY | 63.76% |
| 2020 Q4 | 804.93 Million CNY | 7.82% |
| 2020 FY | 804.93 Million CNY | 12.41% |
| 2020 Q3 | 746.51 Million CNY | 4.86% |
| 2020 Q2 | 711.88 Million CNY | 0.0% |
| 2020 Q1 | - CNY | -100.0% |
| 2019 Q4 | 716.07 Million CNY | 0.0% |
| 2019 FY | 716.07 Million CNY | 36.37% |
| 2018 FY | 525.09 Million CNY | 63.85% |
| 2017 FY | 320.46 Million CNY | 0.0% |